Abstract
As an in vitro model system, patient-derived epidermolysis bullosa simplex keratinocytes have had an immense impact on what we know today about keratin filament function and their role in disease development. In the absence of gene therapy, screening compound libraries for new or better drugs is another approach to improve existing treatments for genodermatoses. However in this study, we report of the potential pitfalls when using this type of cell lines as a “reporter” system. When cell lines with different genetic backgrounds are being used in cell-based assays, the greatest obstacle is to determine the most appropriate culture conditions (i.e., the composition of medium, number of cells plated and number of days in culture). We demonstrate how culture conditions can greatly interfere with the cellular response in cell-based assays (cell proliferation, metabolic activity and migration), potentially also giving rise to misleading data.
References
Beriault DR, Haddad O, McCuaig JV et al (2012) The mechanical behavior of mutant K14–R125P keratin bundles and networks in NEB-1 keratinocytes. PLoS ONE 7:e31320
Chamcheu JC, Lorié EP, Akgul B et al (2009) Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition. J Dermatol Sci 53:198–206
Chamcheu JC, Navsaria H, Pihl-Lundin I et al (2011) Chemical chaperones protect epidermolysis bullosa simplex keratinocytes from heat stress-induced keratin aggregation: involvement of heat shock proteins and MAP kinases. J Invest Dermatol 131:1684–1691
Coulombe PA, Lee CH (2012) Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath. J Invest Dermatol 132:763–775
Fine JD, Eady RAJ, Bauer EA et al (2008) The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol 58:931–950
Fudge DS, Gardner KH, Forsyth VT et al (2003) The mechanical properties of hydrated intermediate filaments: insights from hagfish slime threads. Biophys J 85:2015–2027
Fudge D, Russell D, Beriault D et al (2008) The intermediate filament network in cultured human keratinocytes is remarkably extensible and resilient. PLoS ONE 3:e2327
Kerns ML, DePianto D, Dinkova-Kostova AT et al (2007) Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex. Proc Natl Acad Sci USA 104:14460–14465
Kiuru M, Itoh M, Cairo MS et al (2010) Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 28:371–382
Leachman SA, Hickerson RP, Schwartz ME et al (2009) First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18:442–446
Lu H, Chen J, Planko L, Zigrino P et al (2007) Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J Invest Dermatol 127:2781–2789
Morley SM, D’Alessandro M, Sexton C et al (2003) Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Br J Dermatol 149:46–58
Wagner JE, Ishida-Yamamoto A, McGrath JA et al (2010) Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 363:629–639
Wong T, Gammon L, Liu L et al (2008) Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128:2179–2189
Yamada S, Wirtz D, Coulombe PA (2003) The mechanical properties of epithelial keratins 8 and 18: discriminating between interfacial and bulk elasticities. J Struct Biol 143:45–55
Zhao Y, Gartner U, Smith FJ et al (2011) Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. J Invest Dermatol 131:1045–1052
Acknowledgments
We thank the Slovenian Research Agency for funding our research through grants J3-2274-0381 and J3-3617-0381 to M. Liovic.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zupancic, T., Ozir, M., Törmä, H. et al. Keratinocyte-based cell assays: their potential pitfalls. Arch Dermatol Res 304, 765–768 (2012). https://doi.org/10.1007/s00403-012-1285-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-012-1285-6